Home

arrow iconNewsarrow iconarrow icon

3billion Starts Family Insight Test Using WES, WGS Analysis to Identify Genetic Roots of Unexplained Infertility

3billion Starts Family Insight Test Using WES, WGS Analysis to Identify Genetic Roots of Unexplained Infertility

3billion has gone on to launch the Family Insight Test using WES and WGS analysis aimed at targeting couples who cannot get pregnant for no apparent reason, helping them discover hidden genetic factors affecting fertility.

By FertilityIn

15 Oct 2026

1 min read

3billion has launched the Family Insight Test

3billion has launched the Family Insight Test

3billion, a company that uses artificial intelligence to diagnose rare genetic diseases, said on March 31, 2026, that it has launched the Family Insight Test, a precision genomic diagnostic test for families. Family Insight makes use of WES and WGS analysis to test genetic roots of unexplained infertility with whole exome sequencing - WES and whole genome sequencing - WGS analysis in order to help people and families who have had problems during pregnancy and childbirth or who have a family history of genetic disorders.


3billion has mostly been looking for genetic causes in rare disease patients who have symptoms that lack a clear cause. The company's proprietary AI-based genetic variant interpretation technology is now available to families through the new service. This lets users check ahead of time if a disease is likely to happen.


Taking into account the genetic roots of unexplained infertility, the Family Insight Test is aimed at high-risk groups, such as couples who can't get pregnant for no apparent reason or who have had multiple miscarriages, cases where getting patient samples is hard and family-based alternative diagnosis is needed, and people with a family history of genetic diseases who want to know their own risk ahead of time.


The service also offers Carriership Finding, which looks at differences in autosomal recessive and X-linked disorders across about 2,000 important genes. This looks at the risk of passing on genetic diseases to children even when parents don't show any signs, thereby supporting family planning based on data.


With this launch, 3billion wants to reach more customers than just the genetics specialist-centred market. They want to reach large obstetrics and gynaecology hospitals, in vitro fertilization - IVF clinics, and family planning counselling centres.


Before the service went live, the company ran pilot tests in parts of the Middle East and Africa where a lot of people marry their cousins. This indicated that there was a need for genetic risk management and that the market was viable. The company plans to offer the service in areas with high birth rates, such as Asia and South America, based on these results. Keum Chang-won, CEO of 3billion, said, "We have extended the AI genetic variant interpretation technology accumulated through rare disease diagnosis beyond individuals to the family unit. "Our goal is to reduce genetic uncertainty and support safer family planning."


3billion plans to grow beyond rare disease diagnosis into precision medicine that helps individuals and families make decisions about their genetic risk. This will go on to strengthen its position as an AI genomic data platform company.

73 views

Share

FertilityIn

Send Enquiry for this Story

Related Articles

Canadian Survey Shows 49% Support Federal IVF Funding, While 60% Are Unaware of Treatment Costs

Canadian Survey Shows 49% Support Federal IVF Funding, While 60% Are Unaware of Treatment Costs

A new Ipsos survey commissioned by Fertility Matters Canada finds 49% of Canadians with an opinion support a national baseline for IVF funding support, with backing rising to 59% among those aged 18–34. One in eight Canadians say cost has already forced them or someone close to delay or abandon fertility treatment.

IVF

1 min read

Alpha Controls Named Third-Party Calibration Partner for FertiTech Canada’s Nilotech Temperature Probes

Alpha Controls Named Third-Party Calibration Partner for FertiTech Canada’s Nilotech Temperature Probes

Alpha Controls & Instrumentation Inc. has been selected by FertiTech Canada Inc. as its third-party calibration partner for Nilotech temperature probes. The partnership channels Canadian IVF laboratories and fertility clinics using Nilotech equipment to Alpha Controls for professional, accredited calibration services, while FertiTech continues to handle equipment supply and gas sensor calibration.

IVF

1 min read

MP Seeks Legal Right to Paid Time Off for Fertility Treatment in Commons Bill

MP Seeks Legal Right to Paid Time Off for Fertility Treatment in Commons Bill

In the UK, a Ten Minute Rule Bill has been introduced in the Commons to create a legal right to paid time off for fertility treatment, aiming to standardize access to time‑sensitive appointments and reduce reliance on employer discretion. The proposal seeks House permission to proceed and spotlights workplace rights during Fertility Awareness Week.

IVF

1 min read

Columbia Researchers Report First Pregnancy Using AI-Guided Sperm Recovery Method​

Columbia Researchers Report First Pregnancy Using AI-Guided Sperm Recovery Method​

Columbia University Fertility Center has achieved the first confirmed pregnancy using an AI-guided sperm recovery method in a man with azoospermia, as detailed in The Lancet. The STAR system combined advanced imaging, microfluidics, and robotics to retrieve two viable sperm, enabling embryo creation after prior failed surgical and manual attempts.

IVF

1 min read

B.C. Free IVF Program Funding Depleted, Leaving Patients on Long Waitlist

B.C. Free IVF Program Funding Depleted, Leaving Patients on Long Waitlist

British Columbia's free IVF program exhausts 2025 funding within months of launch. At least one approved clinic stops accepting new applications. Applicants face aging-out risks and must wait until spring 2026 for next funding allocation.

IVF

1 min read

MOH Expands Genetic Conditions Approved for IVF Embryo Testing to 169, Enabling Couples to Reduce Inherited Disease Risks with Govt. Support

MOH Expands Genetic Conditions Approved for IVF Embryo Testing to 169, Enabling Couples to Reduce Inherited Disease Risks with Govt. Support

Singapore’s MOH approves 13 additional genetic conditions for testing before embryos are implanted during IVF, enhancing reproductive genetic screening options.

IVF

1 min read

NHS-Funded IVF in England: Regional Inequalities and Policy Variations Across ICBs

NHS-Funded IVF in England: Regional Inequalities and Policy Variations Across ICBs

National Health Service-funded IVF in England varies across regions in terms of access, cycle definitions, and eligibility. While Integrated Care Boards follow NICE guidelines, local implementation differs to meet specific population needs. Current policy reviews aim to enhance consistency and ensure continued access to fertility services across England.

IVF

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address